Daily Marijuana Observer – Better Know a CTO
Our President and Chief Technology Officer, Dave Berg was recently featured in the The Daily Marijuana Observer – Get to know all about what makes Dave tick, and why he’s so passionate about Strainprint.
5 Unique Facts About Cannabidiol (CBD)
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.
Strainprint Launches Custom App Version For Canna Farms
Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.
Investing News Network: Changing the Limitations of Cannabis Research
On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.
Strainprint Expands Coverage With the Addition of Harvest Medicine
Strainprint™ Technologies Ltd. Expands Nationwide Coverage With the Addition of Harvest Medicine to The Strainprint Community PRESS RELEASE Toronto, August 2, 2017 – Strainprint, the leader in cannabis data collection and strain efficacy reporting [analytics], is pleased to welcome Harvest Medicine cannabis clinic to its growing list of data customers. Based in Calgary, Alberta, Harvest […]
High Canada – Innovation Within The Industry
July 22, 2017 – Strainprint was recently featured in High Canada. Our story focused on innovation within the industry.
Strainprint Announces The Formation of A Board of Medical Advisors
Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Strainprint Announces Partnership With Emblem Cannabis Corp.
Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.
Strainprint Closes Private Investment Round
Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.